At a glance
The August 31, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on molecular testing, reporting COVID-19 test results, lab training, and updates from FDA.

Agenda
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
AMP SARS-CoV-2 Molecular Testing Follow-up Survey: Robyn Temple-Smolkin, Association for Molecular Pathology (AMP)
CMS Update – CLIA Rule for Reporting COVID-19 Test Results: Regina Van Brakle and Amy Zale, Centers for Medicare & Medicaid Services (CMS)
Laboratory Training Update: Joe Rothschild, CDC Division of Laboratory Systems (DLS)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)